Rivista di formazione e di aggiornamento professionale del pediatra e del medico di base, realizzata in collaborazione con l'Associazione Culturale Pediatri
Gli articoli pi� visti nel mese di Marzo 2020
179 kB2) Problemi speciali - Febbraio 2020
SARS-CoV-2: quali implicazioni nella popolazione pediatrica
- V. Giacomet, M. Stracuzzi, V. Rubinacci, G.V. Zuccotti
- By the end of December 2019 there was an outbreak of polmonitis of a new coronavirus named SARS-CoV-2. Until now there have been 76,727 cases, 2,247 deaths and 18,562 healed patients in China and less than 1,200 cases in the rest of the world. Few data are available regarding the epidemiology and the clinical manifestations in the paediatric population, nonetheless the virus seems to be affecting this population way less severely than the adults. This data may be due to an understatement of children’s involvement, since they seem to have very scarce symptoms. The question that arises is: can those mildly symptomatic or asymptomatic paediatric cases infect others therefore enhancing the virus transmission?
3) Editoriali - Marzo 2020
Telemedicina ai tempi del coronavirus
- G. Tornese, A. Scaramuzza, R. Schiaffini
4) News box - Marzo 2020
a cura di Federico MarchettiCovid-19 e bambini: il punto dalla letteratura al 18 marzo
- C. Guiducci, F. Marchetti
5) Aggiornamento - Febbraio 2020
Le infezioni respiratorie ricorrenti
- D. Ferrara, M.C. Vella
- Recurrent respiratory tract infections (RRI) constitute an important public health problem, they are among the main causes of morbidity in paediatric age and one of the most frequent reasons for prescribing antibiotics. Their management has a significant impact on the children’s quality of life and their families, as well as on direct and indirect health costs. It seems that the main strategy to reduce the risk, the number of episodes of RRI and therefore their impact on children, families and society, is prevention that is based on the communication with parents and on the elimination/reduction of risk factors. Immunomodulants/ immunostimulants (IM), whose use is widely discussed in the literature, can be useful in specific cases of difficult family management of children with RRI.
